OrbiMed’s Instil Bio TIL Stock Holding History

OrbiMed’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-116,785	Closed	-$2.03M	–	119
2025 Q1	$2.03M	Hold	116,785	–	–	0.05%	92
2024 Q4	$2.23M	Buy	116,785 +83,085	+247%	+$2.53M	0.05%	100
2024 Q3	$2.27M	Buy	+33,700	New	+$793K	0.04%	108

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

OrbiMed's TIL Position: Q2 2025 in Review

OrbiMed sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 116,785 shares — an estimated $2.03M sold.

OrbiMed first reported a position in TIL in Q3 2024 and held it in 3 quarters. The position peaked at $2.27M in Q3 2024. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

OrbiMed reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
OrbiMed sold 116,785 Instil Bio shares in Q2 2025, an estimated $2.03M.
OrbiMed first reported a position in Instil Bio in Q3 2024 and held it in 3 quarters.
OrbiMed's Instil Bio position peaked at $2.27M in Q3 2024.
38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.